Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Accumulated Expenses (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported Accumulated Expenses of $19.23 million for Q2 2026, up 529.0% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals posted Accumulated Expenses of $4.59 million, down 13.5% from FY2024.

  • By year, Accumulated Expenses came in at $5.3 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.06 million (Q1 2026), $4.59 million (Q4 2025) and $3.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 22.41 Mn
Jun 30, 2026 19.23 Mn
Mar 31, 2026 3.06 Mn
Dec 31, 2025 4.59 Mn
Sep 30, 2025 3.33 Mn
Dec 31, 2024 5.30 Mn
API Access

Lb Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LBRX&period=max&api_key=YOUR_API_KEY